Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00899
Species: Homo sapiens
Position : chr2:16619625-16621501
Year: 2023
Title: TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  37591943
MONDO: MONDO:0004963
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: primary/PDX T-ALL cells
Cell Type: T cell
Cell Ontology ID: CL:0000084
Experiment Type: Enhancer-associated oncogene dependency assay; Functional perturbation assay; In vivo functional validation
High Throughput Method: RNA-seq; primary T-ALL chromatin-data integration
Low Throughput Method: MYCN perturbation; cell-growth assays; xenograft/dependency assays; Western blot; Xenograft/xenotransplant
About Target Gene
Target gene : MYCN
About TF
TF name : TAL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00893 chr2:16619625-16621501 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00894 chr2:16619625-16621501 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00895 chr2:16619625-16621501 blood T cell T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer